Siemens Healthineers AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000SHL1006
EUR
42.69
-3.92 (-8.41%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.23 M

Shareholding (Mar 2024)

FII

0.01%

Held by 2 FIIs

DII

99.99%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Debt Company with a Debt to Equity ratio (avg) at times

  • Poor long term growth as Operating profit has grown by an annual rate 12.09% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 48,109 Million ()

stock-summary
P/E

21.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.23%

stock-summary
Debt Equity

0.81

stock-summary
Return on Equity

13.07%

stock-summary
Price to Book

2.67

Revenue and Profits:
Net Sales:
5,662 Million
(Quarterly Results - Jun 2025)
Net Profit:
556 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.81%
0%
-17.81%
6 Months
-20.24%
0%
-20.24%
1 Year
-22.1%
0%
-22.1%
2 Years
-18.44%
0%
-18.44%
3 Years
-18.96%
0%
-18.96%
4 Years
-10.28%
0%
-10.28%
5 Years
-0.72%
0%
-0.72%

Siemens Healthineers AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
10.08%
EBIT Growth (5y)
11.39%
EBIT to Interest (avg)
18.12
Debt to EBITDA (avg)
2.96
Net Debt to Equity (avg)
0.75
Sales to Capital Employed (avg)
0.62
Tax Ratio
24.22%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
9.64%
ROE (avg)
11.15%
Valuation key factors
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
3.05
EV to EBIT
17.68
EV to EBITDA
13.16
EV to Capital Employed
2.19
EV to Sales
2.85
PEG Ratio
0.94
Dividend Yield
1.99%
ROCE (Latest)
12.37%
ROE (Latest)
14.69%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.01%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 4.41% vs 4.27% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 17.80% vs 4.66% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,662.00",
          "val2": "5,423.00",
          "chgp": "4.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,242.00",
          "val2": "983.00",
          "chgp": "26.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "104.00",
          "val2": "116.00",
          "chgp": "-10.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-131.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "556.00",
          "val2": "472.00",
          "chgp": "17.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "154.00%",
          "val2": "126.90%",
          "chgp": "2.71%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2024 is 3.15% vs -0.16% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2024 is 28.46% vs -25.75% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "22,363.00",
          "val2": "21,680.00",
          "chgp": "3.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,523.00",
          "val2": "3,997.00",
          "chgp": "13.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "476.00",
          "val2": "296.00",
          "chgp": "60.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-431.00",
          "val2": "-204.00",
          "chgp": "-111.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,959.00",
          "val2": "1,525.00",
          "chgp": "28.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "147.60%",
          "val2": "112.50%",
          "chgp": "3.51%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
5,662.00
5,423.00
4.41%
Operating Profit (PBDIT) excl Other Income
1,242.00
983.00
26.35%
Interest
104.00
116.00
-10.34%
Exceptional Items
-131.00
0.00
Consolidate Net Profit
556.00
472.00
17.80%
Operating Profit Margin (Excl OI)
154.00%
126.90%
2.71%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 4.41% vs 4.27% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 17.80% vs 4.66% in Jun 2024

Annual Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
22,363.00
21,680.00
3.15%
Operating Profit (PBDIT) excl Other Income
4,523.00
3,997.00
13.16%
Interest
476.00
296.00
60.81%
Exceptional Items
-431.00
-204.00
-111.27%
Consolidate Net Profit
1,959.00
1,525.00
28.46%
Operating Profit Margin (Excl OI)
147.60%
112.50%
3.51%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Sep 2024 is 3.15% vs -0.16% in Sep 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Sep 2024 is 28.46% vs -25.75% in Sep 2023

stock-summaryCompany CV
About Siemens Healthineers AG stock-summary
stock-summary
Siemens Healthineers AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available